KR 62980

Known as: KR-62980, KR62980 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2015
01220042015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Peroxisome proliferator-activated receptor γ (PPARγ) is a target of antidiabetic drugs. However, many PPARγ activators, including… (More)
Is this relevant?
2011
2011
PPARγ agonists exert neuroprotective effects against various types of brain injuries. In the present study, we investigated the… (More)
Is this relevant?
2011
2011
The pharmacokinetics of a novel peroxisome proliferator-activated receptor-γ agonist, KR-62980, were characterized in vitro with… (More)
Is this relevant?
2011
2011
Peroxisome proliferator-activated receptor γ (PPARγ) activation has anti-angiogenic and apoptotic effects in endothelial cells… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2010
2010
The ligand-activated transcription factor, peroxisome proliferator-activated receptor (PPAR)gamma, and its ligands inhibit pro… (More)
Is this relevant?
2009
2009
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor that plays a pivotal role… (More)
Is this relevant?
2008
2008
1. KR-62980 and its stereoisomer KR-63198 are novel and selective peroxisome proliferator-activated receptor gamma (PPAR gamma… (More)
Is this relevant?
2007
2007
Peroxisome proliferator-activated receptor (PPAR)-gamma ligands have been shown to inhibit human lung cancers by inducing… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) is the target for the anti-diabetic drugs… (More)
Is this relevant?
2006
2006
Peroxisome proliferator-activated receptor-gamma (PPARgamma) activation has been a new approach to cancer therapy. In the present… (More)
Is this relevant?